NASDAQ: QTTB
Q32 Bio Inc Stock Ownership - Who owns Q32 Bio?

Insider buying vs selling

Have Q32 Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Shelia M. VioletteChief Scientific Officer2024-10-156,000$7.29
$43.74kBuy
Shelia M. VioletteChief Scientific Officer2024-10-114,574$3.12
$14.27kBuy
Shelia M. VioletteChief Scientific Officer2024-10-0813,300$3.12
$41.50kBuy

1 of 1

QTTB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when QTTB insiders and whales buy or sell their stock.

QTTB Shareholders

What type of owners hold Q32 Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Arch Venture Fund VIII LP47.29%5,768,694$8.94MInsider
James E. Flynn33.51%4,087,305$6.34MInsider
Diyong Xu18.47%2,252,987$3.49MInsider
Orbimed Advisors LLC18.47%2,252,987$3.49MInsider
Orbimed Advisors LLC18.47%2,252,987$3.49MInstitution
Atlas Venture Life Science Advisors LLC17.15%2,092,106$3.24MInstitution
Atlas Venture Fund X LP17.15%2,092,106$3.24MInsider
David S. Grayzel17.15%2,092,106$3.24MInsider
Carlyle Group Inc9.04%1,102,741$1.71MInstitution
Mahendra Shah7.46%909,742$1.41MInsider

1 of 3

QTTB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
QTTB34.83%65.17%Net Buying
VOR48.80%36.97%Net SellingNet Selling
LEXX8.21%3.91%Net Buying
CVM8.93%28.63%Net BuyingNet Buying
CGTX17.86%41.06%Net SellingNet Selling

Q32 Bio Stock Ownership FAQ

Who owns Q32 Bio?

Q32 Bio (NASDAQ: QTTB) is owned by 90.15% institutional shareholders, 168.65% Q32 Bio insiders, and 0.00% retail investors. Arch Venture Fund VIII LP is the largest individual Q32 Bio shareholder, owning 5.77M shares representing 47.29% of the company. Arch Venture Fund VIII LP's Q32 Bio shares are currently valued at $8.94M.

If you're new to stock investing, here's how to buy Q32 Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.